English (United States)|Italiano (Italia)
English (United States) | Italiano (Italia)
Article details
ITF PHARMA announces FDA approval of TIGLUTIK™ (riluzole) oral suspension for the tratment of amyotrophic lateral sclerosis (ALS)
Created by superuser on 9/6/2018 2:44:49 PM


print
Sort by: